Last reviewed · How we verify
NCT04423354
A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEG
NA trial testing Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Type Ⅱ Adenocarcinoma of Esophagogastric Junction in Esophagogastric Junction Adenocarcinoma in 94 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | Guangdong Provincial Hospital of Traditional Chinese Medicine |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 94 |
| Start date | 25 March 2019 |
| Primary completion | 1 February 2024 |
| Estimated completion | 31 March 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Type Ⅱ Adenocarcinoma of Esophagogastric Junction
Conditions studied
- Esophagogastric Junction Adenocarcinoma — all drugs for Esophagogastric Junction Adenocarcinoma →
- Siewert Type II Adenocarcinoma of Esophagogastric Junction — all drugs for Siewert Type II Adenocarcinoma of Esophagogastric Junction →
Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Who can join
Adults 18 to 78, any sex, with Esophagogastric Junction Adenocarcinoma or Siewert Type II Adenocarcinoma of Esophagogastric Junction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: To evaluate the safety, feasibility and clinical efficacy of transthoracic single-hole assisted laparoscopic radical gastrectomy for Siewert Type Ⅱ adenocarcinoma of esophagogastric junction. Methods: A prospective, single-center, one-arm study will be performed. Patients who have been diagnosed with Siewert type Ⅱ esophagogastric junction adenocarcinoma and meet the eligibility criteria will be included in the study and undergo the transthoracic single-hole assisted laparoscopic radical gastrectomy. The data of preoperative, intraoperative, postoperative and follow-up will be recorded and analyzed. Primary study endpoints: The incidences of early postoperative complications and mortality. The secondary study endpoints:(1) Surgery and oncology indicators ;(2) Early postoperative recovery information ;(3) 3-year disease-free survival and overall survival rate;(4) 5-year disease-free survival and overall survival.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Feasibility and efficacy of transthoracic single-port assisted laparoscopic esophagogastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction.
Luo S, Xu J, Xiong W, Li J, et al · · 2021 · cited 3× · PMID 34790746 · DOI 10.21037/atm-21-4574
Verify or expand the search:
- PubMed search for NCT04423354
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Esophagogastric Junction Adenocarcinoma
Currently open trials in the same condition.
- NCT06761846 — Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ · Phase 2 · recruiting
- NCT06482788 — Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined · Phase 2 · recruiting
- NCT05170503 — Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma · Phase 2 · recruiting
Other Guangdong Provincial Hospital of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT07352137 — Endoscopic Nipple-Sparing Mastectomy (E-NSM) With Immediate Multistage Autologous Fat Grafting(IMAFG) for Total Breast R · NA · enrolling by invitation
- NCT06908473 — Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients · Phase 3 · enrolling by invitation
- NCT06328153 — Efficacy and Mechanism of FSN Treatment for Senile Knee Osteoarthritis · NA · unknown
- NCT06166121 — Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules · NA · unknown
- NCT06001112 — Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04423354 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangdong Provincial Hospital of Traditional Chinese Medicine
- Last refreshed: 9 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04423354.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing